NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Authors :: Shah MH
Goldner WS
Halfdanarson TR
Bergsland E
Berlin JD
Halperin D
Chan J
Kulke MH
Benson AB
Blaszkowsky LS
Eads J
Engstrom PF
Fanta P
Giordano T
He J
Heslin MJ
Kalemkerian GP
Kandeel F
Khan SA
Kidwai WZ
Kunz PL
Kuvshinoff BW
Lieu C
Pillarisetty VG
Saltz L
Sosa JA
Strosberg JR
Sussman CA
Trikalinos NA
Uboha NA
Whisenant J
Wong T
Yao JC
Burns JL
Ogba N
Zuccarino-Catania G
Source :: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2018 Jun; Vol. 16 (6), pp. 693-702.
Publication Year :: 2018
Abstract: The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.<br /> (Copyright © 2018 by the National Comprehensive Cancer Network.)